Global Emergency Hemostatic Agent Market Growth 2020-2025

Publication Month: May 2020 | No. of Pages: 158 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Emergency Hemostatic Agent will have significant change from previous year. By the most conservative estimates of global Emergency Hemostatic Agent market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Emergency Hemostatic Agent market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Emergency Hemostatic Agent market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Emergency Hemostatic Agent, covering the supply chain analysis, impact assessment to the Emergency Hemostatic Agent market size growth rate in several scenarios, and the measures to be undertaken by Emergency Hemostatic Agent companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Surgical Centers
Clnics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Ethicon
Gelita Medical
Pfizer
C. R. Bard
The Medicines Company
Baxter International
Integra LifeSciences
Anika Therapeutics
B Braun Melsungen
Advanced Medical Solutions
BioCer Entwicklungs
Biom'Up SAS
Equimedical
Z-Medica
Marine Polymer Technologies
CryoLife
Vascular Solutions

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Emergency Hemostatic Agent consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Emergency Hemostatic Agent market by identifying its various subsegments.
Focuses on the key global Emergency Hemostatic Agent manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Emergency Hemostatic Agent with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Emergency Hemostatic Agent submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Emergency Hemostatic Agent?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Emergency Hemostatic Agent Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Emergency Hemostatic Agent Consumption 2015-2025
2.1.2 Emergency Hemostatic Agent Consumption CAGR by Region
2.2 Emergency Hemostatic Agent Segment by Type
2.2.1 Gelation Sponge
2.2.2 Oxidized Regenerated Cellulose Based Hemostats
2.2.3 Others
2.3 Emergency Hemostatic Agent Consumption by Type
2.3.1 Global Emergency Hemostatic Agent Consumption Market Share by Type (2015-2020)
2.3.2 Global Emergency Hemostatic Agent Revenue and Market Share by Type (2015-2020)
2.3.3 Global Emergency Hemostatic Agent Sale Price by Type (2015-2020)
2.4 Emergency Hemostatic Agent Segment by Application
2.4.1 Hospitals
2.4.2 Surgical Centers
2.4.3 Clnics
2.4.4 Others
2.5 Emergency Hemostatic Agent Consumption by Application
2.5.1 Global Emergency Hemostatic Agent Consumption Market Share by Type (2015-2020)
2.5.2 Global Emergency Hemostatic Agent Value and Market Share by Type (2015-2020)
2.5.3 Global Emergency Hemostatic Agent Sale Price by Type (2015-2020)

3 Global Emergency Hemostatic Agent by Company
3.1 Global Emergency Hemostatic Agent Sales Market Share by Company
3.1.1 Global Emergency Hemostatic Agent Sales by Company (2018-2020)
3.1.2 Global Emergency Hemostatic Agent Sales Market Share by Company (2018-2020)
3.2 Global Emergency Hemostatic Agent Revenue Market Share by Company
3.2.1 Global Emergency Hemostatic Agent Revenue by Company (2018-2020)
3.2.2 Global Emergency Hemostatic Agent Revenue Market Share by Company (2018-2020)
3.3 Global Emergency Hemostatic Agent Sale Price by Company
3.4 Global Emergency Hemostatic Agent Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Emergency Hemostatic Agent Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Emergency Hemostatic Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Emergency Hemostatic Agent by Regions
4.1 Emergency Hemostatic Agent by Regions
4.2 Americas Emergency Hemostatic Agent Consumption Growth
4.3 APAC Emergency Hemostatic Agent Consumption Growth
4.4 Europe Emergency Hemostatic Agent Consumption Growth
4.5 Middle East & Africa Emergency Hemostatic Agent Consumption Growth

5 Americas
5.1 Americas Emergency Hemostatic Agent Consumption by Countries
5.1.1 Americas Emergency Hemostatic Agent Consumption by Countries (2015-2020)
5.1.2 Americas Emergency Hemostatic Agent Value by Countries (2015-2020)
5.2 Americas Emergency Hemostatic Agent Consumption by Type
5.3 Americas Emergency Hemostatic Agent Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Emergency Hemostatic Agent Consumption by Regions
6.1.1 APAC Emergency Hemostatic Agent Consumption by Regions (2015-2020)
6.1.2 APAC Emergency Hemostatic Agent Value by Regions (2015-2020)
6.2 APAC Emergency Hemostatic Agent Consumption by Type
6.3 APAC Emergency Hemostatic Agent Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Emergency Hemostatic Agent by Countries
7.1.1 Europe Emergency Hemostatic Agent Consumption by Countries (2015-2020)
7.1.2 Europe Emergency Hemostatic Agent Value by Countries (2015-2020)
7.2 Europe Emergency Hemostatic Agent Consumption by Type
7.3 Europe Emergency Hemostatic Agent Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Emergency Hemostatic Agent by Countries
8.1.1 Middle East & Africa Emergency Hemostatic Agent Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Emergency Hemostatic Agent Value by Countries (2015-2020)
8.2 Middle East & Africa Emergency Hemostatic Agent Consumption by Type
8.3 Middle East & Africa Emergency Hemostatic Agent Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Emergency Hemostatic Agent Distributors
10.3 Emergency Hemostatic Agent Customer

11 Global Emergency Hemostatic Agent Market Forecast
11.1 Global Emergency Hemostatic Agent Consumption Forecast (2021-2025)
11.2 Global Emergency Hemostatic Agent Forecast by Regions
11.2.1 Global Emergency Hemostatic Agent Forecast by Regions (2021-2025)
11.2.2 Global Emergency Hemostatic Agent Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Emergency Hemostatic Agent Forecast by Type
11.8 Global Emergency Hemostatic Agent Forecast by Application

12 Key Players Analysis
12.1 Ethicon
12.1.1 Company Information
12.1.2 Emergency Hemostatic Agent Product Offered
12.1.3 Ethicon Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Ethicon Latest Developments
12.2 Gelita Medical
12.2.1 Company Information
12.2.2 Emergency Hemostatic Agent Product Offered
12.2.3 Gelita Medical Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Gelita Medical Latest Developments
12.3 Pfizer
12.3.1 Company Information
12.3.2 Emergency Hemostatic Agent Product Offered
12.3.3 Pfizer Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 C. R. Bard
12.4.1 Company Information
12.4.2 Emergency Hemostatic Agent Product Offered
12.4.3 C. R. Bard Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 C. R. Bard Latest Developments
12.5 The Medicines Company
12.5.1 Company Information
12.5.2 Emergency Hemostatic Agent Product Offered
12.5.3 The Medicines Company Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 The Medicines Company Latest Developments
12.6 Baxter International
12.6.1 Company Information
12.6.2 Emergency Hemostatic Agent Product Offered
12.6.3 Baxter International Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Baxter International Latest Developments
12.7 Integra LifeSciences
12.7.1 Company Information
12.7.2 Emergency Hemostatic Agent Product Offered
12.7.3 Integra LifeSciences Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Integra LifeSciences Latest Developments
12.8 Anika Therapeutics
12.8.1 Company Information
12.8.2 Emergency Hemostatic Agent Product Offered
12.8.3 Anika Therapeutics Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Anika Therapeutics Latest Developments
12.9 B Braun Melsungen
12.9.1 Company Information
12.9.2 Emergency Hemostatic Agent Product Offered
12.9.3 B Braun Melsungen Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 B Braun Melsungen Latest Developments
12.10 Advanced Medical Solutions
12.10.1 Company Information
12.10.2 Emergency Hemostatic Agent Product Offered
12.10.3 Advanced Medical Solutions Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Advanced Medical Solutions Latest Developments
12.11 BioCer Entwicklungs
12.11.1 Company Information
12.11.2 Emergency Hemostatic Agent Product Offered
12.11.3 BioCer Entwicklungs Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 BioCer Entwicklungs Latest Developments
12.12 Biom'Up SAS
12.12.1 Company Information
12.12.2 Emergency Hemostatic Agent Product Offered
12.12.3 Biom'Up SAS Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Biom'Up SAS Latest Developments
12.13 Equimedical
12.13.1 Company Information
12.13.2 Emergency Hemostatic Agent Product Offered
12.13.3 Equimedical Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Equimedical Latest Developments
12.14 Z-Medica
12.14.1 Company Information
12.14.2 Emergency Hemostatic Agent Product Offered
12.14.3 Z-Medica Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Z-Medica Latest Developments
12.15 Marine Polymer Technologies
12.15.1 Company Information
12.15.2 Emergency Hemostatic Agent Product Offered
12.15.3 Marine Polymer Technologies Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Marine Polymer Technologies Latest Developments
12.16 CryoLife
12.16.1 Company Information
12.16.2 Emergency Hemostatic Agent Product Offered
12.16.3 CryoLife Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 CryoLife Latest Developments
12.17 Vascular Solutions
12.17.1 Company Information
12.17.2 Emergency Hemostatic Agent Product Offered
12.17.3 Vascular Solutions Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Vascular Solutions Latest Developments

13 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Emergency Hemostatic Agent Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Emergency Hemostatic Agent Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Emergency Hemostatic Agent Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Gelation Sponge
Table 7. Major Players of Oxidized Regenerated Cellulose Based Hemostats
Table 8. Major Players of Others
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Emergency Hemostatic Agent Consumption Market Share by Type (2015-2020)
Table 11. Global Emergency Hemostatic Agent Revenue by Type (2015-2020) ($ million)
Table 12. Global Emergency Hemostatic Agent Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Emergency Hemostatic Agent Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Emergency Hemostatic Agent Consumption Market Share by Application (2015-2020)
Table 16. Global Emergency Hemostatic Agent Value by Application (2015-2020)
Table 17. Global Emergency Hemostatic Agent Value Market Share by Application (2015-2020)
Table 18. Global Emergency Hemostatic Agent Sale Price by Application (2015-2020)
Table 19. Global Emergency Hemostatic Agent Sales by Company (2017-2019) (K Units)
Table 20. Global Emergency Hemostatic Agent Sales Market Share by Company (2017-2019)
Table 21. Global Emergency Hemostatic Agent Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Emergency Hemostatic Agent Revenue Market Share by Company (2017-2019)
Table 23. Global Emergency Hemostatic Agent Sale Price by Company (2017-2019)
Table 24. Global Emergency Hemostatic Agent Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Emergency Hemostatic Agent Products Offered
Table 26. Emergency Hemostatic Agent Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Emergency Hemostatic Agent Consumption by Regions 2015-2020 (K Units)
Table 28. Global Emergency Hemostatic Agent Consumption Market Share by Regions 2015-2020
Table 29. Global Emergency Hemostatic Agent Value by Regions 2015-2020 ($ Millions)
Table 30. Global Emergency Hemostatic Agent Value Market Share by Regions 2015-2020
Table 31. Americas Emergency Hemostatic Agent Consumption by Countries (2015-2020) (K Units)
Table 32. Americas Emergency Hemostatic Agent Consumption Market Share by Countries (2015-2020)
Table 33. Americas Emergency Hemostatic Agent Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Emergency Hemostatic Agent Value Market Share by Countries (2015-2020)
Table 35. Americas Emergency Hemostatic Agent Consumption by Type (2015-2020) (K Units)
Table 36. Americas Emergency Hemostatic Agent Consumption Market Share by Type (2015-2020)
Table 37. Americas Emergency Hemostatic Agent Consumption by Application (2015-2020) (K Units)
Table 38. Americas Emergency Hemostatic Agent Consumption Market Share by Application (2015-2020)
Table 39. APAC Emergency Hemostatic Agent Consumption by Countries (2015-2020) (K Units)
Table 40. APAC Emergency Hemostatic Agent Consumption Market Share by Countries (2015-2020)
Table 41. APAC Emergency Hemostatic Agent Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Emergency Hemostatic Agent Value Market Share by Regions (2015-2020)
Table 43. APAC Emergency Hemostatic Agent Consumption by Type (2015-2020) (K Units)
Table 44. APAC Emergency Hemostatic Agent Consumption Market Share by Type (2015-2020)
Table 45. APAC Emergency Hemostatic Agent Consumption by Application (2015-2020) (K Units)
Table 46. APAC Emergency Hemostatic Agent Consumption Market Share by Application (2015-2020)
Table 47. Europe Emergency Hemostatic Agent Consumption by Countries (2015-2020) (K Units)
Table 48. Europe Emergency Hemostatic Agent Consumption Market Share by Countries (2015-2020)
Table 49. Europe Emergency Hemostatic Agent Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Emergency Hemostatic Agent Value Market Share by Countries (2015-2020)
Table 51. Europe Emergency Hemostatic Agent Consumption by Type (2015-2020) (K Units)
Table 52. Europe Emergency Hemostatic Agent Consumption Market Share by Type (2015-2020)
Table 53. Europe Emergency Hemostatic Agent Consumption by Application (2015-2020) (K Units)
Table 54. Europe Emergency Hemostatic Agent Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Emergency Hemostatic Agent Consumption by Countries (2015-2020) (K Units)
Table 56. Middle East & Africa Emergency Hemostatic Agent Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Emergency Hemostatic Agent Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Emergency Hemostatic Agent Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Emergency Hemostatic Agent Consumption by Type (2015-2020) (K Units)
Table 60. Middle East & Africa Emergency Hemostatic Agent Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Emergency Hemostatic Agent Consumption by Application (2015-2020) (K Units)
Table 62. Middle East & Africa Emergency Hemostatic Agent Consumption Market Share by Application (2015-2020)
Table 63. Emergency Hemostatic Agent Distributors List
Table 64. Emergency Hemostatic Agent Customer List
Table 65. Global Emergency Hemostatic Agent Consumption Forecast by Countries (2021-2025) (K Units)
Table 66. Global Emergency Hemostatic Agent Consumption Market Forecast by Regions
Table 67. Global Emergency Hemostatic Agent Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Emergency Hemostatic Agent Value Market Share Forecast by Regions
Table 69. Global Emergency Hemostatic Agent Consumption Forecast by Type (2021-2025) (K Units)
Table 70. Global Emergency Hemostatic Agent Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Emergency Hemostatic Agent Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Emergency Hemostatic Agent Value Market Share Forecast by Type (2021-2025)
Table 73. Global Emergency Hemostatic Agent Consumption Forecast by Application (2021-2025) (K Units)
Table 74. Global Emergency Hemostatic Agent Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Emergency Hemostatic Agent Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Emergency Hemostatic Agent Value Market Share Forecast by Application (2021-2025)
Table 77. Ethicon Product Offered
Table 78. Ethicon Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 79. Ethicon Main Business
Table 80. Ethicon Latest Developments
Table 81. Ethicon Basic Information, Company Total Revenue (in $ million), Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors
Table 82. Gelita Medical Product Offered
Table 83. Gelita Medical Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 84. Gelita Medical Main Business
Table 85. Gelita Medical Latest Developments
Table 86. Gelita Medical Basic Information, Company Total Revenue (in $ million), Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors
Table 87. Pfizer Product Offered
Table 88. Pfizer Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Pfizer Basic Information, Company Total Revenue (in $ million), Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors
Table 92. C. R. Bard Product Offered
Table 93. C. R. Bard Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 94. C. R. Bard Main Business
Table 95. C. R. Bard Latest Developments
Table 96. C. R. Bard Basic Information, Company Total Revenue (in $ million), Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors
Table 97. The Medicines Company Product Offered
Table 98. The Medicines Company Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 99. The Medicines Company Main Business
Table 100. The Medicines Company Latest Developments
Table 101. The Medicines Company Basic Information, Company Total Revenue (in $ million), Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors
Table 102. Baxter International Product Offered
Table 103. Baxter International Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 104. Baxter International Main Business
Table 105. Baxter International Latest Developments
Table 106. Baxter International Basic Information, Company Total Revenue (in $ million), Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors
Table 107. Integra LifeSciences Product Offered
Table 108. Integra LifeSciences Basic Information, Company Total Revenue (in $ million), Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors
Table 109. Integra LifeSciences Main Business
Table 110. Integra LifeSciences Latest Developments
Table 111. Integra LifeSciences Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 112. Anika Therapeutics Product Offered
Table 113. Anika Therapeutics Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 114. Anika Therapeutics Main Business
Table 115. Anika Therapeutics Latest Developments
Table 116. Anika Therapeutics Basic Information, Company Total Revenue (in $ million), Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors
Table 117. B Braun Melsungen Product Offered
Table 118. B Braun Melsungen Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 119. B Braun Melsungen Main Business
Table 120. B Braun Melsungen Latest Developments
Table 121. B Braun Melsungen Basic Information, Company Total Revenue (in $ million), Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors
Table 122. Advanced Medical Solutions Product Offered
Table 123. Advanced Medical Solutions Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 124. Advanced Medical Solutions Main Business
Table 125. Advanced Medical Solutions Latest Developments
Table 126. Advanced Medical Solutions Basic Information, Company Total Revenue (in $ million), Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors
Table 127. BioCer Entwicklungs Product Offered
Table 128. BioCer Entwicklungs Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 129. BioCer Entwicklungs Main Business
Table 130. BioCer Entwicklungs Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 131. BioCer Entwicklungs Latest Developments
Table 132. Biom'Up SAS Product Offered
Table 133. Biom'Up SAS Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 134. Biom'Up SAS Main Business
Table 135. Biom'Up SAS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 136. Biom'Up SAS Latest Developments
Table 137. Equimedical Product Offered
Table 138. Equimedical Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 139. Equimedical Main Business
Table 140. Equimedical Latest Developments
Table 141. Equimedical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 142. Z-Medica Product Offered
Table 143. Z-Medica Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 144. Z-Medica Main Business
Table 145. Z-Medica Latest Developments
Table 146. Z-Medica Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 147. Marine Polymer Technologies Product Offered
Table 148. Marine Polymer Technologies Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 149. Marine Polymer Technologies Main Business
Table 150. Marine Polymer Technologies Latest Developments
Table 151. Marine Polymer Technologies Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 152. CryoLife Product Offered
Table 153. CryoLife Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 154. CryoLife Main Business
Table 155. CryoLife Latest Developments
Table 156. CryoLife Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 157. Vascular Solutions Product Offered
Table 158. Vascular Solutions Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 159. Vascular Solutions Main Business
Table 160. Vascular Solutions Latest Developments
Table 161. Vascular Solutions Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Emergency Hemostatic Agent
Figure 2. Emergency Hemostatic Agent Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Emergency Hemostatic Agent Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Emergency Hemostatic Agent Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Gelation Sponge
Figure 7. Product Picture of Oxidized Regenerated Cellulose Based Hemostats
Figure 8. Product Picture of Others
Figure 9. Global Emergency Hemostatic Agent Consumption Market Share by Type (2015-2020)
Figure 10. Global Emergency Hemostatic Agent Value Market Share by Type (2015-2020)
Figure 11. Emergency Hemostatic Agent Consumed in Hospitals
Figure 12. Global Emergency Hemostatic Agent Market: Hospitals (2015-2020) (K Units)
Figure 13. Global Emergency Hemostatic Agent Market: Hospitals (2015-2020) ($ Millions)
Figure 14. Emergency Hemostatic Agent Consumed in Surgical Centers
Figure 15. Global Emergency Hemostatic Agent Market: Surgical Centers (2015-2020) (K Units)
Figure 16. Global Emergency Hemostatic Agent Market: Surgical Centers (2015-2020) ($ Millions)
Figure 17. Emergency Hemostatic Agent Consumed in Clnics
Figure 18. Global Emergency Hemostatic Agent Market: Clnics (2015-2020) (K Units)
Figure 19. Global Emergency Hemostatic Agent Market: Clnics (2015-2020) ($ Millions)
Figure 20. Emergency Hemostatic Agent Consumed in Others
Figure 21. Global Emergency Hemostatic Agent Market: Others (2015-2020) (K Units)
Figure 22. Global Emergency Hemostatic Agent Market: Others (2015-2020) ($ Millions)
Figure 23. Global Emergency Hemostatic Agent Consumption Market Share by Application (2015-2020)
Figure 24. Global Emergency Hemostatic Agent Value Market Share by Application (2015-2020)
Figure 25. Global Emergency Hemostatic Agent Sales Market Share by Company in 2017
Figure 26. Global Emergency Hemostatic Agent Sales Market Share by Company in 2019
Figure 27. Global Emergency Hemostatic Agent Revenue Market Share by Company in 2017
Figure 28. Global Emergency Hemostatic Agent Revenue Market Share by Company in 2019
Figure 29. Global Emergency Hemostatic Agent Sale Price by Company in 2019
Figure 30. Global Emergency Hemostatic Agent Consumption Market Share by Regions 2015-2020
Figure 31. Global Emergency Hemostatic Agent Value Market Share by Regions 2015-2020
Figure 32. Americas Emergency Hemostatic Agent Consumption 2015-2020 (K Units)
Figure 33. Americas Emergency Hemostatic Agent Value 2015-2020 ($ Millions)
Figure 34. APAC Emergency Hemostatic Agent Consumption 2015-2020 (K Units)
Figure 35. APAC Emergency Hemostatic Agent Value 2015-2020 ($ Millions)
Figure 36. Europe Emergency Hemostatic Agent Consumption 2015-2020 (K Units)
Figure 37. Europe Emergency Hemostatic Agent Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Emergency Hemostatic Agent Consumption 2015-2020 (K Units)
Figure 39. Middle East & Africa Emergency Hemostatic Agent Value 2015-2020 ($ Millions)
Figure 40. Americas Emergency Hemostatic Agent Consumption Market Share by Countries in 2019
Figure 41. Americas Emergency Hemostatic Agent Value Market Share by Countries in 2019
Figure 42. Americas Emergency Hemostatic Agent Consumption Market Share by Type in 2019
Figure 43. Americas Emergency Hemostatic Agent Consumption Market Share by Application in 2019
Figure 44. United States Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 45. United States Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 47. Canada Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 49. Mexico Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Emergency Hemostatic Agent Consumption Market Share by Countries in 2019
Figure 51. APAC Emergency Hemostatic Agent Value Market Share by Regions in 2019
Figure 52. APAC Emergency Hemostatic Agent Consumption Market Share by Type in 2019
Figure 53. APAC Emergency Hemostatic Agent Consumption Market Share by Application in 2019
Figure 54. China Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 55. China Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 57. Japan Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 59. Korea Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 61. Southeast Asia Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 62. India Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 63. India Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 65. Australia Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Emergency Hemostatic Agent Consumption Market Share by Countries in 2019
Figure 67. Europe Emergency Hemostatic Agent Value Market Share by Countries in 2019
Figure 68. Europe Emergency Hemostatic Agent Consumption Market Share by Type in 2019
Figure 69. Europe Emergency Hemostatic Agent Consumption Market Share by Application in 2019
Figure 70. Germany Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 71. Germany Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 72. France Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 73. France Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 74. UK Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 75. UK Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 77. Italy Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 79. Russia Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Emergency Hemostatic Agent Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Emergency Hemostatic Agent Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Emergency Hemostatic Agent Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Emergency Hemostatic Agent Consumption Market Share by Application in 2019
Figure 84. Egypt Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 85. Egypt Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 87. South Africa Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 89. Israel Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 91. Turkey Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Emergency Hemostatic Agent Consumption Growth 2015-2020 (K Units)
Figure 93. GCC Countries Emergency Hemostatic Agent Value Growth 2015-2020 ($ Millions)
Figure 94. Global Emergency Hemostatic Agent Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 95. Global Emergency Hemostatic Agent Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 97. Americas Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 98. APAC Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 99. APAC Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 100. Europe Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 101. Europe Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 103. Middle East & Africa Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 104. United States Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 105. United States Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 106. Canada Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 107. Canada Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 108. Mexico Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 109. Mexico Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 110. Brazil Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 111. Brazil Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 112. China Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 113. China Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 114. Japan Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 115. Japan Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 116. Korea Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 117. Korea Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 119. Southeast Asia Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 120. India Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 121. India Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 122. Australia Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 123. Australia Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 124. Germany Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 125. Germany Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 126. France Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 127. France Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 128. UK Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 129. UK Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 130. Italy Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 131. Italy Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 132. Russia Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 133. Russia Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 134. Spain Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 135. Spain Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 136. Egypt Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 137. Egypt Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 138. South Africa Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 139. South Africa Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 140. Israel Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 141. Israel Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 142. Turkey Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 143. Turkey Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 144. GCC Countries Emergency Hemostatic Agent Consumption 2021-2025 (K Units)
Figure 145. GCC Countries Emergency Hemostatic Agent Value 2021-2025 ($ Millions)
Figure 146. Ethicon Emergency Hemostatic Agent Market Share (2018-2020)
Figure 147. Gelita Medical Emergency Hemostatic Agent Market Share (2018-2020)
Figure 148. Pfizer Emergency Hemostatic Agent Market Share (2018-2020)
Figure 149. C. R. Bard Emergency Hemostatic Agent Market Share (2018-2020)
Figure 150. The Medicines Company Emergency Hemostatic Agent Market Share (2018-2020)
Figure 151. Baxter International Emergency Hemostatic Agent Market Share (2018-2020)
Figure 152. Integra LifeSciences Emergency Hemostatic Agent Market Share (2018-2020)
Figure 153. Anika Therapeutics Emergency Hemostatic Agent Market Share (2018-2020)
Figure 154. B Braun Melsungen Emergency Hemostatic Agent Market Share (2018-2020)
Figure 155. Advanced Medical Solutions Emergency Hemostatic Agent Market Share (2018-2020)
Figure 156. BioCer Entwicklungs Emergency Hemostatic Agent Market Share (2018-2020)
Figure 157. Biom'Up SAS Emergency Hemostatic Agent Market Share (2018-2020)
Figure 158. Equimedical Emergency Hemostatic Agent Market Share (2018-2020)
Figure 159. Z-Medica Emergency Hemostatic Agent Market Share (2018-2020)
Figure 160. Marine Polymer Technologies Emergency Hemostatic Agent Market Share (2018-2020)
Figure 161. CryoLife Emergency Hemostatic Agent Market Share (2018-2020)
Figure 162. Vascular Solutions Emergency Hemostatic Agent Market Share (2018-2020)

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets